ID   MZ1851LN
AC   CVCL_X418
SY   MZ 1851-LN; MZ1851 LN
DR   Wikidata; Q54907242
RX   CelloPub=CLPUB00420;
RX   PubMed=17200335;
RX   PubMed=23696916;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E045 ! MZ1851RC
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-09-24; Version: 10
//
RX   CelloPub=CLPUB00420;
RA   Bukur J.H.;
RT   "Characterization of T cell responses against human renal cell
RT   carcinoma and identification of HLA-G as a tumor-associated antigen
RT   and immune evasion mechanism of renal cell carcinoma.";
RL   Thesis PhD (2004); Johannes Gutenberg University Mainz; Mainz; Germany.
//
RX   PubMed=17200335; DOI=10.1158/1078-0432.CCR-06-0824;
RA   Seliger B., Fedorushchenko A., Brenner W., Ackermann A., Atkins D.,
RA   Hanash S.M., Lichtenfels R.;
RT   "Ubiquitin COOH-terminal hydrolase 1: a biomarker of renal cell
RT   carcinoma associated with enhanced tumor cell proliferation and
RT   migration.";
RL   Clin. Cancer Res. 13:27-37(2007).
//
RX   PubMed=23696916; PMCID=PMC3657351;
RA   Stoehr C.G., Buettner-Herold M., Kamphausen E., Bertz S., Hartmann A.,
RA   Seliger B.;
RT   "Comparative expression profiling for human endoplasmic
RT   reticulum-resident aminopeptidases 1 and 2 in normal kidney versus
RT   distinct renal cell carcinoma subtypes.";
RL   Int. J. Clin. Exp. Pathol. 6:998-1008(2013).
//